Loading...
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to moderate ulcerative colitis (UC). Traditionally these agents have required a large pill burden and multiple daily dosing regimens which may account for th...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063115/ https://ncbi.nlm.nih.gov/pubmed/21448448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S5392 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|